| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/17/2009 | EP2068855A2 Aromatic and heteroaromatic compounds useful in treating iron disorders |
| 06/17/2009 | EP2068823A2 Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist |
| 06/17/2009 | EP1485381B1 Azolylaminoazine as inhibitors of protein kinases |
| 06/17/2009 | EP1267883B1 Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin |
| 06/17/2009 | EP1177304B1 Modified factor viia polypeptides |
| 06/17/2009 | CN100500211C Methods of therapy with thrombin derived peptides |
| 06/17/2009 | CN100500193C Extract from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547719 Thrombopoietin mimetic; useful as an agonist of the TPO receptor, particularly in enhancing platelet production; treatment of thrombocytopenia |
| 06/16/2009 | US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/11/2009 | WO2009073669A1 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions |
| 06/11/2009 | WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | WO2009072626A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009072625A1 Amplification method for hematopoietic stem cells with heterocyclic compound |
| 06/11/2009 | WO2009072624A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009071689A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | WO2009071687A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | WO2009071161A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | WO2009051718A3 Calcium receptor modulating agents |
| 06/11/2009 | WO2009007112A4 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 06/11/2009 | WO2008135524A3 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149537 Use of Bile Acid or Bile Salt Fatty Acid Conjugates |
| 06/11/2009 | US20090149513 Compositions of an Orally Active 1,2,4-Oxadiazole for Nonsense Mutation Suppression Therapy |
| 06/11/2009 | US20090149452 Xanthine oxidase inhibitor |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149422 Hemostatic material |
| 06/11/2009 | US20090149388 Dried blood factor composition comprising trehalose |
| 06/11/2009 | US20090149383 Compositions and methods for facilitating heme-iron export from cells |
| 06/11/2009 | US20090148536 plant extracts, herbs; pulverization |
| 06/11/2009 | US20090148533 Ion binding compositions |
| 06/11/2009 | US20090148425 Therapeutic method for blood coagulation disorder |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2707671A1 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | CA2707669A1 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | CA2707667A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | CA2707585A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/10/2009 | EP2067775A1 Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067486A1 Use of CD23 antagonists for the treatment of neoplastic disorders |
| 06/10/2009 | EP2066683A1 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 06/10/2009 | EP2066680A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 06/10/2009 | EP1135122B1 Use of amtolmetin guacyl as for the treatment of intestinal inflammations |
| 06/10/2009 | EP1085900B1 Use of erythropoietin for the treatment of primary haemochromatoses |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497340C Condensed purine derivatives as A1 adenosine receptor antagonists |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/09/2009 | US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 06/09/2009 | US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | CA2583764C Thrombopoietin activity modulating compounds and methods |
| 06/09/2009 | CA2388939C Therapeutic treatments for blood cell deficiencies |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009070684A2 Hemostatic material |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009068214A2 Heteroaryl-substituted piperidines |
| 06/04/2009 | WO2009042962A3 Antidotes for factor xa inhibitors and methods of using the same |
| 06/04/2009 | WO2009040314A3 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2 |
| 06/04/2009 | US20090143473 Use of inhibitors of the cellular na+/h+ exchanger (nhe) for preparing a medicament for normalizing serum lipids |
| 06/04/2009 | US20090143430 Erythropoietin production accelerator |
| 06/04/2009 | US20090143426 Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments |
| 06/04/2009 | US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators |
| 06/04/2009 | US20090143351 Substituted azetidinones |
| 06/04/2009 | US20090143309 converting an agonist of protein kinase C to an antagonist of protein kinase C; amino acid sequences; crosslinked via an N-terminal Cys-Cys bond to a peptide to facilitate transport cellular uptake |
| 06/04/2009 | US20090143302 Pyrimidine compounds |
| 06/04/2009 | US20090143284 administering peptide compound wherein compound is growth hormone-releasing peptide-2 (GHRP-2) or a peptide having an amino acid sequence wherein 3rd amino acid residue from an amino terminus is a modified residue wherein a side chain is acylated by fatty acid; ghrelin is especially desirable |
| 06/04/2009 | US20090143281 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142395 Deferasirox pharmaceutical compositions |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065384A1 Tricyclic thrombin receptor antagonist |
| 06/03/2009 | EP1874341B1 Erythrocytes containing arginine deiminase |
| 06/03/2009 | EP1613319B1 Substituted phenyl acetamides and their use as protease inhibitors |
| 06/03/2009 | EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | CN101448550A Use of strobilurins for treating malfunctions of the iron metabolism |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/03/2009 | CN100493523C Wolf'sclaw (Selaginella moellendorffii Hieron)dry powder extracted using alcohol, and its preparation method |
| 06/02/2009 | US7541449 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells |
| 06/02/2009 | US7541445 synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541341 2-(4-ethylbenzyl)-5-hydroxymethylphenyl 6-O-ethoxycarbonyl- beta -D-glucopyranoside; for treatment/prevention of hyperglycemia associated with diabetes/obesity |
| 06/02/2009 | US7541179 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541029 Anti-rhesus D monoclonal antibodies |
| 06/02/2009 | CA2392025C Process for the preparation of amorphous atorvastatin |
| 06/02/2009 | CA2381187C Intravenous carnitine for the treatment of chronic uraemic patients undergoing periodical dialysis |
| 06/02/2009 | CA2371728C High dose radionuclide complexes for bone marrow suppression |
| 06/02/2009 | CA2362558C Antithrombotic use of glycine betaine |
| 06/02/2009 | CA2340416C Co-lyophilized complex of a nucleic acid vector and a formulating agent |